References:
- Banni S. Conjugated linoleic acid metabolism. Curr Opin Lipidol. 2002
Jun;13(3):261-6. - Dilzer A, Park Y. Implication of conjugated linoleic acid (CLA) in human
health. Crit Rev Food Sci Nutr. 2012;52(6):488-513. - Jaudszus A, Moeckel P, Hamelmann E, Jahreis G. Trans-10,cis-12-CLA-caused
lipodystrophy is associated with profound changes of fatty acid profiles of
liver, white adipose tissue and erythrocytes in mice: possible link to
tissue-specific alterations of fatty acid desaturation. Ann Nutr Metab.
2010;57(2):103-11. - Kim JH, Kim J, Park Y. trans-10,cis-12 Conjugated Linoleic Acid Enhances
Endurance Capacity by Increasing Fatty Acid Oxidation and Reducing Glycogen
Utilization in Mice. Lipids. 2012 Jul 11. - Reynolds CM, Roche HM. Conjugated linoleic acid and inflammatory cell
signalling. Prostaglandins Leukot Essent Fatty Acids. 2010
Apr-Jun;82(4-6):199-204. Epub 2010 Mar 7. - Tanaka T, Hosokawa M, Yasui Y, Ishigamori R, Miyashita K. Cancer
chemopreventive ability of conjugated linolenic acids. Int J Mol Sci.
2011;12(11):7495-509. Epub 2011 Nov 2. - Wang YW, Jones PJ. Conjugated linoleic acid and obesity control: efficacy and
mechanisms. Int J Obes Relat Metab Disord. 2004 Aug;28(8):941-55. Review. - Zhu. Ncb5or in Fatty Acid Desaturation and
Metabolic Diseases. Zhu Diabetes Research Group. University of
Kansas School of Health Professionals. <
http://www.alliedhealth.kumc.edu/school/research/zhu/more_info.html >
retrieved July 22, 2012
No comments:
Post a Comment